BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...

Mild traumatic brain injury (mTBI), a significant public health concern, is diagnosed by clinical assessment and computed tomography (CT) scans, while glial fibrillary acidic protein (GFAP) and ...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is ...

Vaccinex (VCNX) provided an update on new clinical findings from its SIGNAL-AD Phase 1b/2 trial of pepinemab antibody in Alzheimer’s ...

DelveInsight's Neurological Biomarkers Market Insights report provides the current and forecast market analysis, individual ...

Plasma biomarkers differ in adolescents with sport-related concussions and uninjured samples, justifying their use to understand concussion neuropathology.

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare autoimmune disease, which is characterized by the immune system attacking astrocytes in the central nervous system, resulting ...